FiberSense's clinical affairs head speaks at OCT DACH event
Dr. Stephan Theinert joins a Basel panel on future-proofing clinical trials with AI and hosts a discussion on operationalising technology.
See the latest news and media coverage for FiberSense. We track all announcements, press releases, and industry mentions in real time, all in one place.
Optical biosensing and continuous health monitoring company
fibersense-cxm.comLast updated
Dr. Stephan Theinert joins a Basel panel on future-proofing clinical trials with AI and hosts a discussion on operationalising technology.
It showcases its CE-marked 28-day CGM system, previews lifestyle and professional care brands, and welcomes Chief Commercial Officer Lars Kalfhaus.
The new line in Großostheim, Germany automates a key production step for its biosensors, moving toward scalable series manufacturing of its CxM portfolio.
The analysis notes that professional-care CGM adoption may require evidence on workflow integration, handling burden, resource use and health economics as FiberSense pursues a regulatory expansion of its intended use.
BASEL, SWITZERLAND, August 28, 2026 /EINPresswire.com/ — FiberSense AG ("FiberSense") today announced plans to expand the clinical application of its new ...
We are working on a broader portfolio of applications across medical, lifestyle and professional care. The next step will be the introduction of a dedicated...
EQS-News: License partnership with FiberSense AG is being converted into a strategic equity investment...
/PRNewswire/ -- FiberSense AG ('FiberSense') today announced that the FiberSense Continuous Glucose Monitoring (CGM) System has obtained CE marking under Regulation (EU) 2017/745 as a...
Track FiberSense and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to FiberSense and other trending companies.